Experts Discuss the Evolution of CAR T-Cell Therapy in Multiple Myeloma

In this comprehensive program experts provide an overview of CAR T-cell therapy discuss managing CAR T-cell&ndash mediated toxicities and review recent clinical trial data on investigational CAR T-cell therapies for myeloma.

Share

Program Content

Activities

CAR Ts in MM
Overview of CAR T-Cell Therapy in Multiple Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 08, 2022

Expires: July 07, 2023

Investigational CAR Ts in MM
Investigational CAR T-Cell Therapies in Multiple Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 08, 2022

Expires: July 07, 2023

No activities added yet

Faculty

cover img faculity

Jesus G. Berdeja, MD

Director, Multiple Myeloma Program
Sarah Cannon Research Institute
Attending Physician
Sarah Cannon Center for Blood Cancer
Tennessee Oncology
Nashville, Tennessee

cover img faculity

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Janssen administered by Scientific Affairs